<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/864A9845-BA2F-4BF8-AD6D-91B724CF5991"><gtr:id>864A9845-BA2F-4BF8-AD6D-91B724CF5991</gtr:id><gtr:name>Royal Infirmary of Edinburgh</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/98A0166A-44D7-44A0-8876-7824EA20BF4B"><gtr:id>98A0166A-44D7-44A0-8876-7824EA20BF4B</gtr:id><gtr:name>School of Biomedical Sciences</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Biomedical Sciences</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/864A9845-BA2F-4BF8-AD6D-91B724CF5991"><gtr:id>864A9845-BA2F-4BF8-AD6D-91B724CF5991</gtr:id><gtr:name>Royal Infirmary of Edinburgh</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/98A0166A-44D7-44A0-8876-7824EA20BF4B"><gtr:id>98A0166A-44D7-44A0-8876-7824EA20BF4B</gtr:id><gtr:name>School of Biomedical Sciences</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C3A10809-A63E-40BD-9A61-CFB2AF4F619A"><gtr:id>C3A10809-A63E-40BD-9A61-CFB2AF4F619A</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Dickinson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F9EB330F-83C6-434F-BB70-C5948A272C84"><gtr:id>F9EB330F-83C6-434F-BB70-C5948A272C84</gtr:id><gtr:firstName>Dirk</gtr:firstName><gtr:surname>Husmeier</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A968BFB6-F210-44CD-8F3F-123B43B8414F"><gtr:id>A968BFB6-F210-44CD-8F3F-123B43B8414F</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>Ross</gtr:otherNames><gtr:surname>Howie</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/CF15E599-1AB5-44F9-837C-E05E36CDB48D"><gtr:id>CF15E599-1AB5-44F9-837C-E05E36CDB48D</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Ghazal</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A744E04B-9491-4CAE-B4F6-D860F35FD006"><gtr:id>A744E04B-9491-4CAE-B4F6-D860F35FD006</gtr:id><gtr:firstName>Gerard</gtr:firstName><gtr:otherNames>Anthony</gtr:otherNames><gtr:surname>Morris</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/E0869835-3DD1-4176-9E78-389546EC0593"><gtr:id>E0869835-3DD1-4176-9E78-389546EC0593</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:otherNames>Adebayo</gtr:otherNames><gtr:surname>Adegbola</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/23D47341-B294-4027-B1ED-1C5C81B5B51E"><gtr:id>23D47341-B294-4027-B1ED-1C5C81B5B51E</gtr:id><gtr:firstName>Sarah</gtr:firstName><gtr:otherNames>Louise</gtr:otherNames><gtr:surname>Rowland-Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0701289"><gtr:id>4412F673-B5CA-485A-87B7-B09AF43F2A9A</gtr:id><gtr:title>Prospective case-control study of systemic host molecular pathway responses in Gambian infants to pneumococcal pneumonia</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701289</gtr:grantReference><gtr:abstractText>We are looking for natural pathway signals in the body that respond to pneumonia infection. This will help provide more effective treatments.
At present pneumococcal pneumonia is one of the most prevalent bacterial pneumonia, killing up to one million children under five worldwide each year. More than 90% of pneumococcal pneumonia deaths in children occur in developing countries and there remains a critical need to improve child survival and stop the devastating impact of pneumonia.
Understanding the immune response to infection is vital for diagnostic treatment and improving vaccinations. In this application we investigate how and what immune reaction pathways take place in the blood of infants with severe pneumococcal pneumonia. To test this idea we plan to undertake a molecular study of gene activity using very small amounts of blood to identify and mathematically model specific immune response pathways to infection.
The study will explore a new approach using computational science for mapping and understanding the relationships of genes and proteins that can be used to build predictive models of response to an infection. These studies may lead to new insights toward the molecular basis of disease outcome and prediction of treatment response to infection.</gtr:abstractText><gtr:technicalSummary>Understanding the nature of early systemic host responses to pathogen infection is an urgent unmet clinical need that would help in designing better treatments and vaccination approaches for infection of infants. Streptococcus pneumoniae is the leading cause of bacterial pneumonia in children killing up to one million children under five worldwide each year. More than 90% of pneumococcal pneumonia deaths in children occur in developing countries. Here we propose to undertake a prospective case-control molecular profiling study in the Gambia to investigate specific systemic immune response pathways resulting from severe pneumococcal pneumonia in early infancy. This study will apply a computational pathway biology methodology for mapping and understanding the causal relationships in pathways of systemic response. Specifically, in this application we tackle the challenge of combining genome-wide gene expression profiling with bioinformatics with systems level analysis, providing an innovative approach for investigating systemic physiology, and which may lead to new insights toward the molecular basis of disease outcome and prediction of treatment response.</gtr:technicalSummary><gtr:fund><gtr:end>2012-05-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>598553</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Biomedical Sciences</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Pathway Medicine</gtr:department><gtr:description>MRC Gambia and University of Edinburgh Darwin Scholarships</gtr:description><gtr:id>673718C6-DF53-4F7C-9E6D-994741801291</gtr:id><gtr:impact>Ongoing PhD projects in Infectious disease studies along with computational science, bioinformatics, and statistical/mathematical modelling.</gtr:impact><gtr:partnerContribution>Supervision of PhD students</gtr:partnerContribution><gtr:piContribution>Management and supervision of two PhD students</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>Gambia, Republic of the</gtr:country><gtr:department>MRC Unit, The Gambia</gtr:department><gtr:description>MRC Gambia and University of Edinburgh Darwin Scholarships</gtr:description><gtr:id>5EF91E2B-15BA-4F69-9EDE-1385BCE8560E</gtr:id><gtr:impact>Ongoing PhD projects in Infectious disease studies along with computational science, bioinformatics, and statistical/mathematical modelling.</gtr:impact><gtr:partnerContribution>Supervision of PhD students</gtr:partnerContribution><gtr:piContribution>Management and supervision of two PhD students</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Infirmary of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Neonatal Unit, Simpson Centre for Reproductive Health</gtr:department><gtr:description>Neonatal Infection</gtr:description><gtr:id>2E616B49-6551-4B0F-85F0-00C5D186B43F</gtr:id><gtr:impact>One paper has been published detailing the methodological aspects of the project and a further paper detailing the host response to infection is currently under review.</gtr:impact><gtr:partnerContribution>Provision of clinical samples for analysis.</gtr:partnerContribution><gtr:piContribution>Analysis of whole blood transcriptional profiles to examine host response to infection in neonates. We have helped to develop techniques for isolation of RNA from small volumes of blood and have produced a number of Standard Operating Procedures for this. Microarray analysis of transcriptional profiles has been undertaken, data analysed and pathways and network analysis performed. This analysis has resulted in an expression profile that can be used to distinguish bacterial sepsis in neonates and which we would like to clinically validate on larger populations.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Herrenhausen Conference sponsored by the Volkswagen Foundation on &quot;the neonatal window of opportunity - early priming for life</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>08F024D4-BA7F-4D19-AD94-3EA4D1B6B04C</gtr:id><gtr:impact>To Herrenhausen Conference is an international recognized platform for inspiring dialogue on topical and socially relevant research issues. Recent epidemiological and experimental studies shed light on the critical and non-redundant role of the immediate postnatal period for the susceptibility to allergies and chronic inflammatory diseases during later light. This novel concept of an early &amp;quot;Window of Opportunity&amp;quot; that determines long-term health and disease susceptibility represents a paradigm shift in our understanding of the aetiology of human immune-mediated diseases and may ultimately impact on the clinical management and care of neonates and young children.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to Edinburgh International Science Festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8E01C492-B255-47CA-BC44-69D06E00140D</gtr:id><gtr:impact>A talk was presented showing how viruses may contribute beneficial genes to future generations which generated lively discussion and debate afterwards.

The talk generated lively discussion and interest from the lay audience and media.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Gambia government-MRC meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7CF00BD3-35D0-4D51-A5F7-39BF49E48B5B</gtr:id><gtr:impact>reporting on and discussing research results and plans and priorities

Progress towards consensus on priorities and activities</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2006,2007,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited lecture tour by Australasian Society for Immunology, to include talk at ASI 2014 Conference, December 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BBE27FD6-7441-43CD-9890-18416E0A613F</gtr:id><gtr:impact>Collaborative science projects to include new grant applications

Not yet</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker at Neonatal Update: Science of Newborn Care, Imperial College</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2513F717-11D8-4201-AF18-5E70CDF413D9</gtr:id><gtr:impact>Special Lecture and breakout discussions

Collaborative networks formed</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Gambian radio</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>AA3B1761-0D45-49F9-B461-BC42672C260D</gtr:id><gtr:impact>The Field Coordinator for the Severe Pneumonia Studies does radio talk back shows on several radio stations in The Gambia once or twice a year. The purpose of these is to raise awareness about pneumonia and about our research, as well as to dispell common misconceptions about MRC research in general.

These radio programmes are well received. It is clear to the field team that people they are encountering in the community are more likely to have some basic knowledge about pneumonia and are keener to participate in research projects.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker to Gordon Research Conference, Immunochemistry &amp; Immunoobiology, Maine, USA</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7A5274D8-FB56-4899-8C63-3EE08FC3C61C</gtr:id><gtr:impact>Meeting potential collaborators

New collaborations and projects</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Gambia government-MRC meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>22F0697D-1583-46C1-84E5-BB5FBA3B004E</gtr:id><gtr:impact>reporting on and discussing research results and plans and priorities

Progress towards consensus on priorities and activities</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2006,2007,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Keystone Symposia Conference - Asthma: From Pathway Biology to Precision Therapeutics</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E6E60501-1418-4EC1-9EC8-82AE45D0E514</gtr:id><gtr:impact>To present our work on Neonatal sepsis and to describe the scientific basis for pathway biology-a terminology first proposed by Professor Ghazal.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker, Edinburgh Perinatal Festival.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>524E7836-3636-4CFA-B947-1581976871FE</gtr:id><gtr:impact>Presentation and discussions

Making contact with clinicians/researchers</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1314300</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>ClouDx-i - Cloud Based Software Solution for Next Generation Diagnostics in Infectious Diseases</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Community Research and Development Information Service (CORDIS)</gtr:fundingOrg><gtr:fundingRef>324365</gtr:fundingRef><gtr:id>8CA31F0B-EBCE-4283-835E-159CF48E8197</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5993000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>EU FP7 - NeoVanc</gtr:description><gtr:end>2019-01-02</gtr:end><gtr:fundingOrg>European Commission (EC)</gtr:fundingOrg><gtr:fundingRef>EC 602041 NeoVanc</gtr:fundingRef><gtr:id>AED64723-0C66-4FAE-9CC2-98897F1B7E27</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>219897</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Chief Scientist Office (CSO)</gtr:department><gtr:description>CSO Research Grants</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>Scottish Government</gtr:fundingOrg><gtr:fundingRef>ETM/202</gtr:fundingRef><gtr:id>731B23C6-EFDF-4580-9003-3FDDB8CFFCB8</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2012-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>289261</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Molecular profiling consortium: biomarker identification and interaction analysis of Expanded Programme on Immunisation (EPI) vaccines</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0701291</gtr:fundingRef><gtr:id>D81FD435-27D1-4812-9BEF-004CE4777132</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The describes pathway biomarker set for accurate diagnosis of sepsis, integrating innate immune, adaptive and metabolic pathways specific to bacterial septicaemia. The has been validated in multiple independent population groups from pre-term infants to adults on multiple continents.</gtr:description><gtr:id>EEB3BB81-E969-4984-9ECD-EC1DBBC4C367</gtr:id><gtr:impact>Provides a deeper understanding of the human host immune response in early and adult life to sepsis. Identifies novel pathways associated with sepsis and that can be targeted for therapeutic intervention.</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:patentId>WO2015155517A1</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Molecular Predictors of Sepsis</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>We have entered into an evaluation licence with MRCT to assess the transferability of &amp;quot;Sepsis Classifier&amp;quot; from a microarray platform onto other platforms. Further the prosecution of the patent into national territories with applications in the US and EU has been completed.</gtr:description><gtr:id>FAE47187-CD83-4596-AAB9-22DFBE31DA40</gtr:id><gtr:impact>We have entered into an evaluation licence with MRCT to assess the transferability of &amp;quot;Sepsis Classifier&amp;quot; from a microarray platform onto other platforms.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>W02015155517</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Molecular predictors of sepsis</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NIH/NIAID Human Immunology Project Consortium (HIPC) 2011</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>DC40AB40-71CF-4B29-9557-2842B5AE575B</gtr:id><gtr:impact>Member of the HIPC Scientific Advisory Board, helped to formulate policy in this area.</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BBSRC research committee 2009</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>3A3945BC-6D64-4C08-8316-D5BF2C33197F</gtr:id><gtr:impact>Pool member of BBSRC research committee helped formulate policy in this area.</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BBSRC research committee 2010</gtr:description><gtr:geographicReach>Local/Municipal/Regional - UK Only</gtr:geographicReach><gtr:id>8A66D184-E979-4D2C-8586-3F198D533930</gtr:id><gtr:impact>Pool member of BBSRC research committee helped formulate policy in this area.</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>UoE, CMVM, Public Engagement Committee 2009</gtr:description><gtr:geographicReach>Local/Municipal/Regional - UK Only</gtr:geographicReach><gtr:id>DCB5A98E-3F16-48B9-A2B6-4BFE1F554127</gtr:id><gtr:impact>Member of Public engagement committee, University of Edinburgh, College of Medicine and Veterinary Medicine - helped formulate policy in this area.</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NIH/NIAID review panel for Human Immunology 2010</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>75FF7893-9B74-440B-A2FF-F24E23CE21F1</gtr:id><gtr:impact>Member of NIH/NIAID review panel for Human Immunology 2010, helped formulate policy in this area</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NIH/NIAID Review Panel, Translational research on human immunology and bio-defence (U19)</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>3AD4753E-CD3A-40E9-B476-616BE63C6E66</gtr:id><gtr:impact>Member of NIH/NIAID review panel for Translational research on human immunology and bio-defence to help shape policy in this area</gtr:impact><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chair, Sanger Institute Virus Advisory Board 2010</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>C7C52E43-480D-4937-841B-BC94DDFA2B05</gtr:id><gtr:impact>Chaired the Sanger Institute Virus Advisory Board to help formulate policy.</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>UoE, CMVM, Public Engagement Committee 2007</gtr:description><gtr:geographicReach>Local/Municipal/Regional - UK Only</gtr:geographicReach><gtr:id>F3CD197A-003B-4E0E-BA89-CAEFE1F47B06</gtr:id><gtr:impact>Member of Public engagement committee, University of Edinburgh, College of Medicine and Veterinary Medicine - helped formulate policy in this area.</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>UoE, CMVM, Public Engagement Committee 2008</gtr:description><gtr:geographicReach>Local/Municipal/Regional - UK Only</gtr:geographicReach><gtr:id>BF4C2A89-5B36-4CA5-9C4C-34EB73863B9F</gtr:id><gtr:impact>Member of Public engagement committee, University of Edinburgh, College of Medicine and Veterinary Medicine - helped formulate policy in this area.</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NCE of Canada 2009</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>6ECFF988-EF1D-403B-9371-59DE69CAC66A</gtr:id><gtr:impact>Member on expert panel for networks of centres of excellence (NCE) of Canada. Initiative of NSERC, CIHR, SSHRC and industry Canada. 2009, helped formulate policy in this area.</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>INBIOMEDvision Think Tank on genotype-phenotype resources 2011</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>28012F95-2503-4247-AE0C-1F98BE095AB2</gtr:id><gtr:impact>Participated in Think Tank on genotype-phenotype resources, as part of the INBIOMEDvision project activities</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>The R package opBiomarker was developed and is freely available for academic use from the Comprehensive R Archive Network (http://www.cran.r-project.org/web/packages/optBiomarker/)</gtr:description><gtr:id>FBBDCDB1-2311-4B4F-910C-8F1F664838C5</gtr:id><gtr:impact>The optBiomarker package was used in the publication 'MULTI-FACTORIAL ANALYSIS OF CLASS PREDICTION ERROR: ESTIMATING OPTIMAL NUMBER OF BIOMARKERS FOR VARIOUS CLASSIFICATION RULES' Khondoker, M. etal. Journal of Bioinformatics and Computational Biology Vol. 8, No. 6 (December 2010)</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>optBiomarker</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:url>http://www.cran.r-project.org/web/packages/optBiomarker/</gtr:url><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Fios Genomics Ltd.</gtr:companyName><gtr:description>Fios Genomics offers computational innovative solutions to overcome challenges in genomic microarray analysis and achieve biologically insightful results rapidly. Optimised analysis solutions are applied from data generation, quality and statistical filtering to network and mechanistic pathway biology to streamline workflows for predictive accuracy and cost-effective report outputs. More details on Fios Genomics Ltd. can be obtained at http://www.fiosgenomics.com/</gtr:description><gtr:id>D66329E9-4B40-4E70-863B-E9C85A0632A1</gtr:id><gtr:impact>The company has been involved in over 100 different projects and is an SME partner on a number of grants. The company currently employs the equivalent of 9 full time scientific posts.</gtr:impact><gtr:url>http://www.fiosgenomics.com</gtr:url><gtr:yearCompanyFormed>2008</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/622FE22B-EFCA-44B5-9733-82735ECF5496"><gtr:id>622FE22B-EFCA-44B5-9733-82735ECF5496</gtr:id><gtr:title>Sex-Differential Non-Vaccine-Specific Immunological Effects of Diphtheria-Tetanus-Pertussis and Measles Vaccination.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5f0d00d6e320109e2364260747ad667c"><gtr:id>5f0d00d6e320109e2364260747ad667c</gtr:id><gtr:otherNames>Noho-Konteh F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F0A7A108-2F9C-4C2D-AFF8-C357476340F3"><gtr:id>F0A7A108-2F9C-4C2D-AFF8-C357476340F3</gtr:id><gtr:title>Multi-factorial analysis of class prediction error: estimating optimal number of biomarkers for various classification rules.</gtr:title><gtr:parentPublicationTitle>Journal of bioinformatics and computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7b352efb039ec8f0359feec847c3310d"><gtr:id>7b352efb039ec8f0359feec847c3310d</gtr:id><gtr:otherNames>Khondoker MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0219-7200</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1F407A2C-6014-40C3-AA9D-E6556EBC1F6F"><gtr:id>1F407A2C-6014-40C3-AA9D-E6556EBC1F6F</gtr:id><gtr:title>Early life response to infection.</gtr:title><gtr:parentPublicationTitle>Current opinion in infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7ae4b712d5f57c293a458fcb9e63c97d"><gtr:id>7ae4b712d5f57c293a458fcb9e63c97d</gtr:id><gtr:otherNames>Ghazal P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0951-7375</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CF12DBCC-25D9-4EC1-91AE-046FC0D5E336"><gtr:id>CF12DBCC-25D9-4EC1-91AE-046FC0D5E336</gtr:id><gtr:title>Whole blood gene expression profiling of neonates with confirmed bacterial sepsis.</gtr:title><gtr:parentPublicationTitle>Genomics data</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d1b654f1a34936beafd1d3ff8f13acfd"><gtr:id>d1b654f1a34936beafd1d3ff8f13acfd</gtr:id><gtr:otherNames>Dickinson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-5960</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E8D2F726-5960-4CAF-8A7F-9C7D3E4A9195"><gtr:id>E8D2F726-5960-4CAF-8A7F-9C7D3E4A9195</gtr:id><gtr:title>Applying statistical inference in genomics with evidence-based pathways: Towards elucidating new functional correlations of biomarkers</gtr:title><gtr:parentPublicationTitle>European Pharmaceutical Review</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7ae4b712d5f57c293a458fcb9e63c97d"><gtr:id>7ae4b712d5f57c293a458fcb9e63c97d</gtr:id><gtr:otherNames>Ghazal P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/94F69233-CFC2-4465-83D6-C7FD783A4146"><gtr:id>94F69233-CFC2-4465-83D6-C7FD783A4146</gtr:id><gtr:title>Identification of a human neonatal immune-metabolic network associated with bacterial infection.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e7a2eaed345ae795011f7075771aae4e"><gtr:id>e7a2eaed345ae795011f7075771aae4e</gtr:id><gtr:otherNames>Smith CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C541F218-B816-48C8-A0BC-1004316D5E75"><gtr:id>C541F218-B816-48C8-A0BC-1004316D5E75</gtr:id><gtr:title>SPRINT: taking biomedical analysis from the desktop to supercomputers and the cloud</gtr:title><gtr:parentPublicationTitle>EPCC, University of Edinburgh</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/661e94e5c506848071a09bbe73568607"><gtr:id>661e94e5c506848071a09bbe73568607</gtr:id><gtr:otherNames>Sloan, T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E6B13D8D-8415-47EC-8172-34C1D1923A79"><gtr:id>E6B13D8D-8415-47EC-8172-34C1D1923A79</gtr:id><gtr:title>SPRINT: more runners, fewer hurdles</gtr:title><gtr:parentPublicationTitle> Edinburgh Parallel Computing Centre</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/84d2ff6d0076e82b52ac146b3ca07f93"><gtr:id>84d2ff6d0076e82b52ac146b3ca07f93</gtr:id><gtr:otherNames>Robertson, K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3788A0AD-36E9-4A2F-ACB8-547A97C36A68"><gtr:id>3788A0AD-36E9-4A2F-ACB8-547A97C36A68</gtr:id><gtr:title>Transcriptional profiling technology for studying vaccine responses: an untapped goldmine.</gtr:title><gtr:parentPublicationTitle>Methods (San Diego, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e16dca02a00616648b5fb16d77916ef0"><gtr:id>e16dca02a00616648b5fb16d77916ef0</gtr:id><gtr:otherNames>Flanagan KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1046-2023</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701289</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>